Literature DB >> 1727757

Mechanism of insulin resistance in CCl4-induced cirrhosis of rats.

A Meyer-Alber1, H Hartmann, F Stümpel, W Creutzfeldt.   

Abstract

Insulin action was studied in rats with CCl4/phenobarbital-induced cirrhosis of the liver using the euglycemic hyperinsulinemic clamp technique coupled with isotopic measurement of individual tissue glucose uptake, glycogen formation, and lipogenesis. In cirrhotic rats, dose response curves showed a reduction of insulin-stimulated total body glucose disposal of about 30%. Insulin action on tissue glucose uptake and initial phosphorylation (assessed with [3H]2-deoxyglucose) were unchanged; however, incorporation of [14C]glucose into lipids and particularly into glycogen was reduced substantially (being most pronounced in skeletal muscle and diaphragm) at maximally as well as half-maximally effective serum insulin concentrations during euglycemic clamping. At identical IV insulin infusion rates, steady-state serum insulin concentrations were elevated up to fourfold in cirrhotic animals. Antilipolytic action of insulin was unaltered. These data suggest that the principal metabolic pathway affected in insulin resistance of rats with experimental cirrhosis appeared to be insulin-stimulated glycogen formation in muscle tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727757     DOI: 10.1016/0016-5085(92)91804-d

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

2.  Serum hepatocyte growth factor as an index of extensive catabolism of patients awaiting liver transplantation.

Authors:  C Miki; A D Mayer; J A Buckels; K Iriyama; H Suzuki; P McMaster
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

3.  Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.

Authors:  O Selberg; W Burchert; J vd Hoff; G J Meyer; H Hundeshagen; E Radoch; H J Balks; M J Müller
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 4.  Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk.

Authors:  Anna L Lang; Juliane I Beier
Journal:  Biol Chem       Date:  2018-10-25       Impact factor: 4.700

5.  Evaluation of phytochemical content, antimicrobial, cytotoxic and antitumor activities of extract from Rumex hastatus D. Don roots.

Authors:  Sumaira Sahreen; Muhammad Rashid Khan; Rahmat Ali Khan; Taibi Ben Hadda
Journal:  BMC Complement Altern Med       Date:  2015-07-03       Impact factor: 3.659

6.  Evaluation of biological potential of selected species of family Poaceae from Bahawalpur, Pakistan.

Authors:  Iram Fatima; Sobia Kanwal; Tariq Mahmood
Journal:  BMC Complement Altern Med       Date:  2018-01-24       Impact factor: 3.659

7.  Antimicrobial activity, toxicity and anti-inflammatory potential of methanolic extracts of four ethnomedicinal plant species from Punjab, Pakistan.

Authors:  Rabia Naz; Hafsa Ayub; Sajid Nawaz; Zia Ul Islam; Tayyaba Yasmin; Asghari Bano; Abdul Wakeel; Saqib Zia; Thomas H Roberts
Journal:  BMC Complement Altern Med       Date:  2017-06-08       Impact factor: 3.659

8.  Protective effect of Sophora pachycarpa seed extract on carbon tetrachloride-induced toxicity in rats.

Authors:  Hamed Aramjoo; Pouria Mohammadparast-Tabas; Tahereh Farkhondeh; Mahmoud Zardast; Marzieh Makhdoumi; Saeed Samarghandian; Zahra Kiani
Journal:  BMC Complement Med Ther       Date:  2022-03-17

9.  Assessment of phytochemicals, antimicrobial and cytotoxic activities of extract and fractions from Fagonia olivieri (Zygophyllaceae).

Authors:  Umbreen Rashid; Muhammad Rashid Khan; Shumaila Jan; Jasia Bokhari; Naseer Ali Shah
Journal:  BMC Complement Altern Med       Date:  2013-07-10       Impact factor: 3.659

10.  Estimation of flavoniods, antimicrobial, antitumor and anticancer activity of Carissa opaca fruits.

Authors:  Sumaira Sahreen; Muhammad Rashid Khan; Rahmat Ali Khan; Naseer Ali Shah
Journal:  BMC Complement Altern Med       Date:  2013-12-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.